E-LIB Suche - Ergebnisse für: Chalabiyev, Elvin - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

The efficacy of palbociclib and ribociclib in the first-lin..:

Yıldırım, Hasan Çağrı ; Kutlu, Yasin ; Mutlu, Emel...
International Journal of Clinical Oncology. 29 (2024) 3 - p. 258-265 , 2024

Link: https://doi.org/10.1007/..

2

Advances in the Early Detection of Hepatobiliary Cancers:

Yıldırım, Hasan Çağrı ; Kavgaci, Gozde ; Chalabiyev, Elvin.
Cancers. 15 (2023) 15 - p. 3880 , 2023

Link: https://doi.org/10.3390/..

3

Do statins enhance the antitumor effect of trastuzumab emta..:

Akyildiz, Arif ; Guven, Deniz Can ; Yildirim, Hasan Cagri...
Medicine. 102 (2023) 18 - p. e33677 , 2023

Link: https://doi.org/10.1097/..

4

Immunogenicity of two doses of inactive COVID‐19 vaccine an..:

Guven, Deniz Can ; Incesu, Fatma Gul Gulbahce ; Yildirim, Hasan Cagri...
International Journal of Cancer. 152 (2022) 4 - p. 679-685 , 2022

Link: https://doi.org/10.1002/..

5

Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) ..:

Yıldırım, Hasan Çağrı ; Mutlu, Emel ; Chalabiyev, Elvin...
The Breast. 66 (2022) - p. 85-88 , 2022

Link: https://doi.org/10.1016/..

6

Do statins enhance the antitumor effect of trastuzumab emta..:

Akyildiz, Arif ; Guven, Deniz Can ; Yildirim, Hasan Cagri...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158859/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Prognostic Value of Androgen Receptor Expression in Premeno..:

Yalçin, Şuayib ; Dizdar, Ömer ; GÜVEN, DENİZ CAN...
84011cac-67c1-42e4-9bc2-09f0874d499d. , 2023

Link: https://doi.org/10.37047..

8

Advances in the Early Detection of Hepatobiliary Cancers:

Chalabiyev, Elvin ; DİZDAR, ÖMER ; YILDIRIM, HASAN ÇAĞRI.
afd17c8d-c0d5-473f-bdca-fde545457e44. , 2023

Link: https://doi.org/10.3390/..

9

Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) ..:

Yildirim, Hasan Cagri ; Mutlu, Emel ; Chalabiyev, Elvin...
Breast. , 2022

Link: https://hdl.handle.net/1..

10

Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) ..:

DURSUN, BENGÜ ; YILDIRIM, HASAN ÇAĞRI ; MUTLU, EMEL...
047289ff-9f63-4daa-8762-ccee65a6a04b. , 2022

Link: https://doi.org/10.1016/..

11

Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) ..:

DURSUN, BENGÜ ; YILDIRIM, HASAN ÇAĞRI ; MUTLU, EMEL...
047289ff-9f63-4daa-8762-ccee65a6a04b. , 2022

Link: https://doi.org/10.1016/..

12

Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) ..:

DURSUN, BENGÜ ; GÜVEN, DENİZ CAN ; YILDIRIM, HASAN ÇAĞRI...
047289ff-9f63-4daa-8762-ccee65a6a04b. , 2022

Link: https://doi.org/10.1016/..

13

Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) ..:

Yıldırım, Hasan Çağrı ; Mutlu, Emel ; Chalabiyev, Elvin..
10.1016/j.breast.2022.09.009. , 2022

Link: https://hdl.handle.net/2..

14

Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) ..:

Yıldırım, Hasan Çağrı ; Mutlu, Emel ; Chalabiyev, Elvin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547301/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) ..:

Mutlu, Emel ; Yildirim, Hasan Cagri ; Chalabiyev, Elvin...
Breast. , 2022

Link: https://hdl.handle.net/1..

1-15